Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Study: New Engineered Particles Train the Body to Accept Allergens

FDA Delays Approval of Aquestive’s Anaphylm™ Sublingual Epinephrine Film

Nasus Pharma’s Nasal Epinephrine Powder Shows Faster Relief Than EpiPen

GSK’s $2.2 Billion Acquisition of Rapt Signals a New Era for Food Allergy Treatments

Beyond Desensitization: How PRT120 Rewires the Immune System for Peanut Allergy Remission

Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...

Discovery Could Lead To Personalized Medical Therapies for Emerging New Food...

Intrommune Therapeutics Seeks Crowdfunding for Novel Toothpaste Immunotherapy

Study: Vaccine Suppresses Peanut Allergies in Mice

Aimmune to Submit FDA Application for Peanut OIT Candidate by End...

Milk and Peanut Clinical Trial Advances

Study: Protein Active in Life-Threatening Allergic Reactions is a Promising Target...

Study: Researchers Retrained Immune Systems of Mice to Switch Off Anaphylaxis

Results of Phase III Trial of Aimmune's Peanut OIT Therapy

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

Your School On Our Map

Put Your School on the Map